Correction: Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT (Journal of Hematology & Oncology, (2023), 16, 1, (58), 10.1186/s13045-023-01450-4)

Nagler, A.; Labopin, M.; Blaise, D.; Raiola, A. M.; Corral, L. L.; Bramanti, S.; Sica, S.; Kwon, M.; Koc, Y.; Pavlu, J.; Kulagin, A.; Busca, A.; Rodriguez, A. B.; Remenyi, P.; Schmid, C.; Brissot, E.; Sanz, J.; Bazarbachi, A.; Giebel, S.; Ciceri, F.; Mohty, M.

doi:10.1186/s13045-023-01501-w

The original article [1] incorrectly presents Affiliation 7. The correct affiliation can be viewed ahead in this Correction article: 7Transplantation Unit Department of Oncology and Haematology, IRCCS Humanitas Research Hospital, Milan, Italy.

Correction: Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT (Journal of Hematology & Oncology, (2023), 16, 1, (58), 10.1186/s13045-023-01450-4) / Nagler, A., Labopin, M., Blaise, D., Raiola, A.M., Corral, L.L., Bramanti, S., Sica, S., Kwon, M., Koc, Y., Pavlu, J., Kulagin, A., Busca, A., Rodriguez, A.B., Remenyi, P., Schmid, C., Brissot, E., Sanz, J., Bazarbachi, A., Giebel, S., Ciceri, F., et al.. - In: JOURNAL OF HEMATOLOGY & ONCOLOGY. - ISSN 1756-8722. - 16:1(2023). [10.1186/s13045-023-01501-w]